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A B S T R A C T   
A crucial factor in the pathogenesis of orthopedics associated infections is that bacteria do not only colonize the 
implant surface but also the surrounding tissues. This study aimed to engineer an antimicrobial release coating 
for stainless steel (SS) surfaces, to impart them with the ability to prevent Staphylococci colonization. Chlor-
hexidine (CHX) was immobilized using two polydopamine (pDA)-based approaches: a one-pot synthesis, where 
CHX is dissolved together with dopamine before its polymerization; and a two-step methodology, comprising the 
deposition of a pDA layer to which CHX is immobilized. To modulate CHX release, an additional layer of pDA 
was also added for both strategies. 
Immobilization of CHX using a one-step approach yielded surfaces with a more homogenous coating and less 
roughness than the other strategies. The amount of released CHX was lower for the one-step approach, as 
opposed to the two-step approach yielding the higher release, which could be decreased by applying an outward 
layer of pDA. Both one and two-step approaches provided the surfaces with the ability to prevent bacterial 
colonization of the surface itself and kill most of bacteria in the bulk phase up to 10 days. This long-term 
antimicrobial performance alluded a stable and enduring immobilization of CHX. In terms of biocompatibility, 
the amount of CHX released from the one-step approach did not compromise the growth of mammalian cells, 
contrary to the two-step strategy. Additionally, the few bacteria that managed to adhere to surfaces modified 
with one-step approach did not show evidence of resistance towards CHX. 
Overall data underline that one-step immobilization of CHX holds great potential to be further applied in the 
fight against orthopedic devices associated infections.   
1. Introduction 
Orthopedic implants have been widely used to restore the function of 
load-bearing joints, reducing the pain and improving the life quality of 
millions of people every year [1]. Knee and hip replacements are the 
most common procedures in this field and it has been estimated that by 
the end of 2030, the number of total knee arthroplasties and hip re-
placements will grow 673% and 174%, respectively, just in the United 
States [2]. Inserting an implant in the body is always associated with the 
risk of microbial infection. Indeed, infection is one of the major com-
plications in orthopedics, being the cause of failure of total hip and knee 
arthroplasties in 1 to 5% of the almost half a million annually performed 
worldwide [3,4]. 
Upon implantation, the fate of a biomaterial has been described as a 
race between its integration into the surrounding tissue and bacterial 
adhesion to its surface [5]. When successful, the race is won by tissue 
cells and the surface will be less vulnerable to bacterial colonization. 
Conversely, if the race is won by bacteria, the implant surface will 
become rapidly covered by a biofilm, a structured community of 
adhering cells encased in a self-produced polymeric matrix [5,6]. Once 
established, biofilm-associated infections are extremely difficult to treat 
because cells within biofilms are less susceptible to both antimicrobial 
treatment and the host immune system. Furthermore, the emerging 
microbial resistance towards the widely prescribed antibiotics compro-
mises their successful use for treatment purposes [7]. Staphylococcus 
aureus and coagulase-negative staphylococci such as S. epidermidis are 
the two most frequently implicated organisms in prosthetic joint in-
fections, with incidence rates of 24–43% and 12–26%, respectively [8]. 
The more desirable option to fight biomaterial-associated infections 
(BAI) relies, therefore, on the development of materials able to resist 
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bacterial colonization in the first place, while enhancing tissue inte-
gration [9]. Several surface modifications have been proposed to 
address these infections, including impregnation with compounds such 
as silver or antibiotics [10,11]. Orthopedic devices currently in the 
market, and approved for human clinical use, are based on antibiotic 
eluting [12,13]. Such strategies, however, are not able to fully address 
the increasing infection rates while antibiotics overuse paves a strong 
selective pressure on bacteria, resulting in the emergence and spread of 
resistant bacteria [14]. Chlorhexidine (CHX), an antiseptic biguanide 
compound, has been described as a promising compound to be immo-
bilized on the surface of implants and, therefore, replace the need to use 
antibiotics in the treatment of BAI [15]. Its appealing features include 
mostly its efficiency against a broad spectrum of relevant pathogens, 
including Gram-positive and Gram-negative bacteria and yeasts. In 
addition, it has already been accounted for a number of applications, 
including oral and skin antiseptics [16,17], as well as in intracorporeally 
used medical devices such as catheters and meshes [18,19]. Another 
promising feature involves CHX substantivity, since this agent not only 
has an immediate antimicrobial effect but it also persists for periods of 
time longer than the application period [20,21]. As a positively charged 
molecule, it has been postulated that CHX’s main mode of action is 
mainly based on interactions with the anionic phosphate residue of the 
lipid molecules in the cell membrane, bypassing the cell wall exclusion 
mechanism, in which it causes intracellular components leakage and 
cytoplasm content precipitation [22,23]. 
Amongst the great number of coating strategies reported to impart 
the surfaces of biomaterials with the ability to resist microbial coloni-
zation [24], mussel-inspired polydopamine (pDA) has aroused re-
searcher’s attention mainly due to its simple processing conditions, 
material independency, strong reactivity for secondary functionaliza-
tion and positive interactions with mammalian cells [25]. This coating 
strategy, based on a mussel adhesive protein, was first described in 2007 
by Messersmith and co-workers and it comprises the immersion of 
substrates in an alkaline solution of dopamine, which self- 
polymerization results in the deposition of an adhesive film with 
nanometer thickness [26]. It has been successfully applied for the 
immobilization of antifungals, antimicrobial peptides and enzymes to 
render the surfaces of biomaterials with anti-infective properties 
[27–29]. 
The main purpose of the present study was to explore this mussel- 
inspired coating strategy to tailor the immobilization and subsequent 
release of CHX from stainless steel (SS) surfaces, in order to both prevent 
S. aureus and S. epidermidis attachment to these surfaces and impair 
bacterial growth in their surroundings. 
2. Materials and methods 
2.1. Bacterial strains and growth conditions 
The reference strain ATCC 25923 Staphylococcus aureus (purchased 
by the American Type Culture Collection) and the reference strain CECT 
231 Staphylococcus epidermidis (purchased by the Spanish Type Culture 
Collection) were used in this study. Bacteria were first streaked on a 
tryptic soy agar (TSA, Liofilchem) plate, from a frozen stock solution and 
grown for 24 h at 37 ◦C. A few colonies were then collected from the TSA 
plates and grown overnight in batches of tryptic soy broth (TSB, Lio-
filchem) at 37 ◦C under agitation (OS-20, 120 rpm). Cells were harvested 
by centrifugation (9000g, 5 min) and washed in sterile saline solution 
(0.9% NaCl). The concentration of cellular suspensions was adjusted by 
measuring the absorbance at 620 nm (EZ Read 800 Plus, Biochrom) and 
using an established standard curve for each species. 
2.2. Determination of minimal inhibitory and bactericidal concentrations 
The minimal inhibitory (MIC) and bactericidal (MBC) concentrations 
of CHX (Sigma, Portugal) were determined by the microdilution 
method, in accordance to Clinical and Laboratory Standards Institute 
(formerly NCCLS) [30]. Briefly, the wells of sterile 96-well round- 
bottom microtiter plates (polystyrene, Orange, USA) were filled with 
100 μL of TSB with increasing concentrations of CHX, to which were 
added 100 μL of each bacterium inoculums (adjusted to a final con-
centration of 5.0 × 105 CFU mL− 1). The final concentration of CHX 
tested was in the range of 0.19–50 μg mL− 1. The plates were afterwards 
incubated at 37 ◦C for 24 h in an orbital shaker (OS-20, 120 rpm). In this 
assay, two controls were used: culture media without bacteria, as a 
negative control, and bacterial suspension growth without antimicro-
bials, as a positive control. Moreover, culture media with increasing 
concentrations of antimicrobials without bacteria were also performed 
in order to avoid misleading results. The MIC was obtained by measuring 
the absorbance at 620 nm (A620nm), in which clear wells (A620nm =
A620nm of negative control) were evidence of bacterial growth inhibi-
tion. MBC determination was performed by adding a droplet of 10 μL 
from each well with no visible growth on a TSA plate. The lowest con-
centration that yielded no colony growth after 24 h at 37 ◦C was iden-
tified as the MBC. 
2.3. Stainless steel preparation and further functionalization 
Stainless steel 316 (Ramada Aços, Portugal) was cut into 1 cm × 1 cm 
squares. Prior to surface modification, an ultrasonic cleaning pre- 
treatment was performed to remove all impurities and traces of 
grease. For that, samples were sonicated in distilled water, acetone and 
ethanol for 10 min in each solution, being afterwards sterilized by 
autoclaving at 121 ◦C for 15 min. SS modification and functionalization 
were performed using a mussel-inspired coating strategy as illustrated in 
Fig. 1. For CHX immobilization using 1-step approach (Fig. 1A), dopa-
mine (Sigma, 2 mg mL− 1) and CHX (2 mg mL− 1) were dissolved together 
in 10 mM bicine buffer (Sigma, pH 8.5) and the SS coupons were 
immediately placed in this solution. After an overnight incubation at 
room temperature and 70 rpm, the coupons were rinsed with ultrapure 
water and air-dried before further utilization. In the 2-step approach 
(Fig. 1B), SS coupons were first immersed in a freshly prepared solution 
of dopamine (2 mg mL− 1 in bicine buffer, pH 8.5) for 18 h, at room 
temperature and 70 rpm. After dopamine polymerization, the coupons 
were rinsed with ultrapure water and, for further functionalization with 
CHX, pDA-coated coupons were immersed in a CHX solution (2 mg mL− 1 
in bicine buffer, pH 8.5), and incubated overnight at room temperature 
under agitation (70 rpm). The CHX concentration in the prepared so-
lution was confirmed by measuring its absorbance at 255 nm (Fig. S1 of 
supporting information). Attempting to modulate CHX release, for both 
strategies, an additional layer of pDA was added (Fig. 1C) by immersing 
the modified coupons on a freshly prepared solution of dopamine (2 mg 
mL− 1 in bicine buffer, pH 8.5) for 18 h, at room temperature under 
agitation (70 rpm). Finally, to prepare a contact-killing approach with 
no antimicrobial release, for comparison purposes, a commercially 
available solution containing chlorhexidine gluconate and PEG (Paro-
dontax®, called PTX) was immobilized onto SS surfaces, following the 
two-step pDA-based approach. 
2.4. Surfaces characterization 
Morphological analyses were performed in an ultra-high resolution 
Field Emission Gun Scanning Electron Microscopy (FEG-SEM, NOVA 
200 Nano SEM, FEI Company). Prior to its observation, samples were 
covered with a very thin film of Au–Pd (80–20 wt%). Topographic 
images were obtained with a secondary electron detector using the 
following parameters: an acceleration voltage of 10 kV, 6.7 mm stage 
distance, and 1000× and 10,000× magnification. Chemical analyses 
were performed with the Energy Dispersive Spectroscopy (EDS) tech-
nique, using an EDAX Si(Li) detector with an acceleration voltage of 4 
kV. Fourier transform infrared (FTIR) spectra of the surfaces were 
recorded with a Bruker Alpha II spectrometer in Attenuated Total 
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Reflectance mode (ATR) with a platinum accessory in the wavenumber 
range: 4000–500 cm− 1, using 64 scans at a resolution of 4 cm− 1. Surface 
morphology and roughness were further analyzed with atomic force 
microscopy (AFM). AFM measurements were performed at room tem-
perature using a Multimode with a Nanoscope III from Digital In-
struments (USA) operating in tapping mode. Scan rates were set at 1.0 
Hz and the scanning area per sample was fixed at 5 μm × 5 μm. Surface 
morphology and roughness analysis were conducted using Gwyddion 
software. Surface wettability was investigated by measuring SS static 
water contact angle after each deposition step, by a sessile drop method 
using an automated contact angle measurement apparatus (OCA 15 
Plus, Dataphysics, Germany) that allows image acquisition and data 
analysis. Contact angles were measured using 3 μL drops of water. 
2.5. CHX release profile 
To determine CHX release profile, modified coupons were placed in 
6-well microtiter plates (Orange Scientific, USA) to which 4 mL of PBS 
(phosphate buffered saline, pH 7.4) were added, being after constantly 
agitated at 120 rpm and 37 ◦C. The PBS was all collected and refreshed 
by adding more 4 mL of PBS, at different time points (every hour in the 
first 6 h and every 24 h up to 72 h). The amount of released CHX was 
then determined by ultraviolet-visible spectroscopy (UV–Vis), 
measuring the absorbance at 255 nm. The absorbance values were then 
converted to concentration values using a calibration curve previously 
established. 
2.6. Antimicrobial and leaching properties of modified surfaces 
Antimicrobial properties of prepared surfaces were evaluated as 
previously reported, with some modifications [27]. Briefly, 20 μL of a 
bacterial suspension adjusted to approximately 106 CFU mL− 1 were 
added on top of each surface and incubated under static conditions at 
37 ◦C. When the drop was dried, coupons were placed on a TSA plate, 
with the face exposed to bacterial suspension in contact with the agar, 
and they were incubated at 37 ◦C for 24 h. Bacterial growth was then 
evaluated for the tested surfaces and tabulated as “+” for growth and “-” 
for no visible growth. To determine the possible leaching of CHX from 
the modified surfaces, a qualitative method previously reported was 
used [27]. Surfaces were placed on top of TSA plates previously streaked 
with a bacterial suspension adjusted to a concentration of approximately 
108 CFU mL− 1. Plates were then incubated for 72 h at 37 ◦C and the 
presence or absence of an inhibition zone was observed. The inhibition 
zone was an indication of CHX release from the surfaces. Three inde-
pendent assays with three replicates for each condition were performed. 
2.7. Antimicrobial performance of modified surfaces 
Antimicrobial activity of the generated surfaces against bacterial 
adhesion and subsequent biofilm formation was evaluated by preparing 
a bacterial suspension with 106 CFU mL− 1 in TSB from overnight cul-
tures of both species. SS coupons were then placed into the wells of a 24- 
well microtiter plate (Orange Scientific, USA) and covered with 1 mL of 
each bacterial suspension. The samples were kept at 37 ◦C and 120 rpm 
for 24 h and 10 days. For the 10 days experiments, 50% of bacterial 
suspension was removed and filled with fresh TSB, every 24 h. The su-
pernatants were recovered, and the coupons were washed twice with 
saline solution and transferred to new wells filled with 1 mL of saline 
solution. Adhered cells were removed from the SS coupons by ultrasonic 
bath in a Sonicor SC-52 (Sonicor Instruments) operating at 50 kHz, 
during 6 min (parameters previously optimized). The resulting bacterial 
suspensions were afterwards collected, gently vortexed to disrupt 
possible cell aggregates, serially 10-fold diluted, and plated into TSA 
plates that were incubated overnight at 37 ◦C in an aerobic incubator 
prior enumeration. 
2.8. Assessment of antimicrobial resistance development by planktonic 
cultures exposed to CHX 
The potential resistance development was first evaluated for plank-
tonic cells with CHX in solution, adapting a procedure previously 
described by Cooper et al. [31]. Briefly, 20 μL of an overnight culture of 
S. aureus was inoculated in 10 mL of TSB medium containing a sub- 
inhibitory concentration of CHX (0.195 mg/L). The flask was then 
incubated at 37 ◦C and 120 rpm for 24 h. For 10 successive days, similar 
and freshly prepared flasks were inoculated with 20 μL of the preceding 
days’ culture. The MIC and MBC of CHX was determined, as afore-
mentioned, on days 0 and 10. Three independent assays were 
performed. 
2.9. Evaluation of modified surfaces potential to induce bacterial 
resistance 
To evaluate the potential development of resistance of cells adhered 
Fig. 1. Schematic representation of coating strategies developed for CHX immobilization on SS surfaces. In the one-step approach (A), SS was immersed in dopamine 
together with CHX (1step-CHX). For the two-step approach (B) SS was first immersed on dopamine solution, which self-polymerization leads to the formation of a 
pDA coating which can afterwards serve as the platform for the immobilization of CHX (2step-CHX). An additional layer of pDA (C) was also tested by the follow 
immersion on dopamine solution (1step-CHX-pDA and 2step-CHX-pDA). 
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towards the immobilized CHX on the SS surfaces, a previously reported 
procedure [28] was adapted, in which cells adhered to the surfaces with 
and without modification were collected after 10 days of exposure to 
these surfaces. Briefly, 1 mL of a bacterial suspension with 107 CFU 
mL− 1 prepared in TSB was added to a 24-well microtiter plate in which 
SS, pDA, and pDA further functionalized with CHX using both one and 
two-step approaches (2step-CHX and 1step-CHX) and Parodontax (PTX) 
were individually placed. The plate was incubated for 10 days at 37 ◦C 
and 120 rpm, with TSB replacement every 24 h. After 10 days, the 
coupons were subsequently washed twice with saline solution to remove 
free-floating bacteria, and transferred to new wells filled with 1 mL of 
TSB. Adhered cells were removed by ultrasonic bath as aforementioned, 
being the number of viable cells determined by CFU counts. The 
recovered cells were adjusted to the same concentration and used for 
MIC and MBC determination. 
2.10. Cytotoxicity determination 
Cytotoxicity was evaluated on fibroblast 3T3 (CCL-163) cells ob-
tained from ATCC, according to the ISO 10993-5:2006 [32]. Cells were 
grown in Dulbecco modified eagle medium (DMEM, Gibco) supple-
mented with 10% of fetal bovine serum (FBS, Gibco) and 1% antibiotics 
(ZellShield™, Biochrom) at 37 ◦C and 5% CO2. Once achieved the 
confluence, cells were detached using trypsin and 100 μL of cell sus-
pension, adjusted to 1 × 105 cells mL− 1, were transferred to each well of 
a 96-well plate. In parallel, unmodified and modified surfaces were 
inserted in 24-well plates and 1 mL of DMEM was added to each well. 
Both plates with cells and surfaces were incubated for 24 h at 37 ◦C and 
5% CO2. After this period, cells supernatant was removed and 100 μL of 
the medium, which was in contact with the surfaces, were added. Fresh 
DMEM was also added as a positive control. Plate was then incubated for 
additional 24 h at 37 ◦C, 5% CO2. In the dark, 20 μL of MTS (3-(4,5- 
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 
2H-tetrazolium) inner salt (Promega) were added to each well and the 
plate was further incubated for 1 h at 37 ◦C, 5% CO2. The absorbance of 
the resulting solution was measured at 490 nm. The percentage of cells 
viability was calculated by the ratio between the cell growth in the 
presence of coating and the control growth (cells growth in DMEM). 
Three independent experiments in triplicate were performed. 
2.11. Statistical analysis 
Statistical analysis was performed by Kolmogorov-Smirnov 
normality test using Graph Pad Prism 7.0. After this analysis, para-
metric tests (one-way ANOVA followed by Tukey’s test) or nonpara-
metric (Kruskal− Wallis test) were used, depending on whether the 
samples were from normally distributed populations or not, respec-
tively. In all the analysis performed, the confidence interval used was 
95%. 
3. Results 
3.1. Stainless steel functionalization with CHX 
To impart SS surfaces with the ability to resist bacterial colonization, 
several pDA-based strategies were explored for the immobilization of 
CHX (Fig. 1). For the one-step pDA-based coating strategy (Fig. 1A), SS 
coupons were dipped in a mixture of dopamine and CHX. In the two-step 
approach (Fig. 1B), substrata were first dipped in a solution of dopa-
mine, with its self-polymerization resulting in the deposition of a pDA 
coating. The quinone functional groups of pDA will allow the covalent 
grafting of nucleophilic CHX via Michael addition and/or Schiff base 
reactions [33]. Considering that CHX has no primary but secondary 
amines, its reactivity should be lower [34] than other compounds pre-
viously immobilized such as enzymes and peptides with primary amines 
or thiol groups [33]. However, secondary amines should react with 
carbonyl groups on polydopamine layer to form enamines [35]. On the 
other hand, the very nature of the functionalization process, which in-
volves surfaces immersion on a solution of CHX, led us to assume that 
some physical adsorption may occur. Aiming to control the CHX release, 
a third approach - comprising the deposition of an additional layer of 
pDA to both strategies (Fig. 1C) - was followed. 
The generated coating strategies performance was first evaluated 
considering their ability to kill bacteria and CHX release from the sur-
faces (Table 1). 
Results showed that both one-step and two-step pDA-based ap-
proaches were successful in the immobilization of CHX on SS surfaces, as 
evidenced by their antimicrobial activity against S. epidermidis and 
S. aureus. For both strategies, it was also observed an inhibition zone 
which indicates CHX release from the surfaces. Further modification of 
one-step pDA-based strategy with another layer of pDA masked the 
antimicrobial activity of CHX, as evidenced by the absence of antimi-
crobial activity and inhibition zones. Based on these features, this 
approach was, therefore, no further considered for the following anal-
ysis. After adding an additional layer of pDA to the two-step approach, 
immobilized CHX retained its antimicrobial activity and the ability to 
release from the surfaces. However, a smaller inhibition zone was 
observed, as compared to the simple two-step approach, which suggests 
a different release profile (Fig. S2). 
In addition to these antimicrobial-releasing surfaces, a contact- 
killing design with no antimicrobial release was prepared by the 
immobilization of a commercially available solution containing chlor-
hexidine gluconate and PEG (Parodontax®) following the two-step pDA- 
based approach (PTX). Results showed that this strategy imparted SS 
surfaces with contact-killing activity, while no CHX release was 
observed. Therefore, no other pDA-based strategies were explored for 
PTX immobilization. 
3.2. Surface characterization 
3.2.1. Chemical composition 
Chemical analyses of the surfaces were performed using EDS to 
confirm each modification step (Table 2). Results showed that bare SS is 
an alloy composed mostly by Iron (Fe) in combination with Nickel (Ni), 
Carbon (C) and Oxygen (O). It is also composed by other elements but in 
vestigial amounts, therefore, they were not detected. Polydopamine 
deposition could be confirmed by the decrease of Fe and Ni amounts 
accompanied by the increase on C and N composition. The presence of 
Fe and Ni detected on all the coating strategies may be attributed to the 
sampling depth achieve by the EDS, which is higher than 50 nm 
(maximal thickness of pDA-based coatings) [26,36]. It is expected, 
therefore, that SS chemical signature will be always detected. CHX 
immobilization was suggested for both one-step and two-step ap-
proaches taking into account the continuous decrease on Fe and Ni 
composition and the increase on C content. A greater reduction on Fe 
Table 1 
Antimicrobial activity and qualitative release of CHX from SS surfaces func-
tionalized with CHX/PTX, using different pDA-based coating strategies. Visible 
growth was used as an indication of antimicrobial activity being tabulated as 
“+” for bacterial growth and “–” for no growth. Release of CHX/PTX was 
evaluated by the presence (P) or absence (A) of an inhibition zone.  
Coating 
strategies 









1step-CHX − P − P 
2step-CHX − P − P 
1step-CHX- 
pDA 
+ A + A 
2step-CHX- 
pDA 
− P − P 
PTX − A − A  
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and Ni composition was found when an additional layer of pDA was 
incorporated. Parodontax immobilization yielded surfaces with a 
chemical signature similar to pDA coating alone. However, the presence 
of PEG and the other compounds of this formulation may play a role on 
such results. 
CHX immobilization, using both one and two-step pDA-based ap-
proaches, was also corroborated by ATR-FTIR analysis (Fig. S4). Results 
showed that bare SS before and after dopamine polymerization (pDA) 
exhibited very similar spectra. According to Daud et al. [37], polydop-
amine presence should be evidenced by the appearance of N–H 
stretching vibrations in the secondary amine at 3360 cm− 1 and primary 
amine at 1606 cm− 1. The absence of peaks in our samples may be 
attributed to the fact that we used a 10-fold lower concentration of 
dopamine, which may have prevented the detection of these charac-
teristic peaks. Further functionalization of surfaces with CHX using both 
one and two-step approaches resulted in the appearance of a peak be-
tween 2850 and 3000 cm− 1, which corresponds to alkane C–H 
stretching vibrations derived from the long hydrocarbon chain of CHX, 
as previously reported [37]. Although less evident, physical adsorption 
of CHX without polydopamine as an intermediate also exhibited this 
characteristic peak. 
3.2.2. Surface morphology 
Surface morphology was evaluated by SEM analysis (Fig. 2). Results 
showed that unmodified SS exhibited the typical microstructure of the 
laminated surfaces of SS, characterized by the presence of randomly 
aligned grooves and ridges [38,39]. After pDA coating, it was possible to 
observe the presence of self-polymerized pDA particles resulting from 
the bulk solution, which has been previously reported [25]. Further 
functionalization with CHX resulted in different morphologies, 
depending on the approach used. One-step immobilization of CHX 
yielded surfaces with a more homogeneous appearance with agglom-
erates more evenly distributed along the surfaces, as previously reported 
[29,40]. When CHX was immobilized using the two-step approach, no 
significant differences were found as compared to pDA coating alone. 
The addition of another layer of pDA generated surfaces with more and 
bigger pDA agglomerates across the entire surface. SS functionalization 
with PTX resulted in a cloudlike surface morphology, mainly observed 
by AFM (Fig. S3), which may be attributed to the presence of PEG in its 
formulation [41]. 
3.2.3. Surface roughness and wettability and CHX release profile 
Using the AFM analysis, it was also possible to measure the average 
roughness of surfaces (Fig. 3A). Results showed that pDA coating did not 
introduce significant changes on surface roughness as well as further 
functionalization with CHX following a two-step approach or with a 
subsequent addition of another layer of pDA. One-step approach, on the 
other hand, caused a reduction on the surface roughness while PTX 
immobilization generated surfaces with significant higher values of 
roughness. 
Surface wettability before and after each modification step was 
investigated by measuring the static water contact angles (Fig. 3B). Bare 
SS exhibited a hydrophobic surface, as evidenced by the water contact 
angle of approximately 94.1◦ ± 5.1◦. Further functionalization with pDA 
rendered SS with hydrophilic properties as evidenced by the decrease on 
the water contact angle to 46.8◦ ± 6.0◦, which is a well-established 
observation on materials functionalized with pDA [28]. Whatever the 
followed approach, further functionalization with CHX did not interfere 
with this hydrophilic character provided by sole pDA coating. These 
results are not in accordance to Daud et al. [37], reporting that CHX 
immobilization using a two-step pDA-based approach increased the 
hydrophobicity of the modified surfaces. These found differences may be 
attributed to the pre-treatment of SS surfaces performed by these au-
thors, as opposed to the samples used in this study. SS roughness seemed 
to be more determinant on the contact angle measured than the 
Table 2 
EDS quantification of atomic compositions of SS surfaces before and after 
different pDA-based coating strategies for the immobilization of CHX/PTX.  
Surfaces C (%) O (%) N (%) Fe (%) Ni (%) 
SS  18.34  15.66  0.00  52.71  13.29 
pDA  32.36  14.41  8.33  36.27  8.63 
1step-CHX  50.27  15.72  7.00  21.99  5.02 
2step-CHX  46.39  14.02  9.54  24.71  5.34 
2step-CHX-pDA  56.85  13.79  9.47  16.23  3.67 
PTX  37.90  12.32  10.40  31.95  7.43  
Fig. 2. Surface morphology characterization. SEM analysis of SS surfaces before and after different pDA-based coating strategies for the immobilization of CHX/PTX. 
The scale bars in the left and right column indicate 100 and 10 μm, respectively 
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immobilized CHX. Immobilization of PTX, on the other hand, greatly 
improved the hydrophilicity of SS surfaces, which may be attributed to 
the presence of PEG in this formulation and the previously demonstrated 
cloudlike arrangement [42]. 
The release profile of CHX from the different coating strategies is 
presented in Fig. 3C. Results showed that for all antimicrobial-releasing 
coating strategies, CHX was released in a burst-release fashion way, with 
most of the release occurring in the first 3 h. The quantity of released 
CHX, however, varied with the immobilization strategy. Higher amounts 
were found for the two-step approach, while no CHX release was 
detected for the immobilization of PTX. This higher amount of released 
CHX may be attributed to some of the aforementioned physical 
adsorption. As intended, the amount of released CHX could be decreased 
(15-fold) by applying an outward layer of pDA or by using one-step 
immobilization strategy. These results corroborate the qualitative 
release assay previously showed in Table 1 and Fig. S2. It has been 
demonstrated that the amount of immobilized compounds depends on 
the performed pDA-based approach [40]. Therefore, the amount of 
released CHX may be a consequence of a higher efficiency of immobi-
lization using the two-step approach. 
Since immobilization of CHX, using a two-step approach followed by 
an additional layer of pDA (2step-CHX-pDA) and the one-step approach 
(1step-CHX), exhibited a similar CHX release profile, the latter approach 
was chosen for further investigation, as it comprises a simpler and less 
time-consuming coating strategy. 
3.3. Antimicrobial performance of coatings 
To evaluate the antimicrobial performance of the coating strategies 
against S. aureus and S. epidermidis, surfaces were first exposed to bac-
terial suspensions for 24 h. The number of adhered cells and the cells 
found around the SS coupons, in the bulk phase, were enumerated 
(Fig. 4A and B). 
Results showed that both species were able to adhere to unmodified 
SS surfaces and a higher number of adhered cells was found for S. aureus, 
as compared to S. epidermidis (Fig. 4A). The presence of pDA had no 
interference on the adhesion of S. aureus while enhancing the attach-
ment of S. epidermidis, as noticed by the higher number of adhered cells. 
CHX immobilization using both one-step and two-step approaches was 
able to completely prevent the attachment of S. epidermidis. When it 
comes to S. aureus, both strategies impaired the surfaces of SS with 
similar antimicrobial features, causing a significant reduction on the 
number of adhered cells to an average number below the detection limit. 
The observed variability for these conditions is attributed to the range of 
log between 0 (when no colonies are found) and 2 (when only one 
colony is detected). Immobilization with PTX only caused reductions of 
approximately 1.4 and 1.6 log on the adhesion of S. epidermidis and 
S. aureus, respectively. Since the goal of this study was to prevent bac-
terial adhesion to the modified surfaces themselves, while also eradi-
cating the cells in their surroundings, the number of cells in the bulk 
phase was also determined (Fig. 4B). Results showed that SS before or 
after pDA coating did not interfere with both species growth. Bacterial 
growth was, however, compromised in the presence of all modified 
surfaces. Immobilization of CHX using both one and two-step ap-
proaches caused reductions on the number of cells to an average number 
below the detection limit. In a similar way to what was found for the 
adhered cells, surfaces functionalized with PTX exhibited less antimi-
crobial activity as compared to other strategies, with reductions of 
approximately 4.5 and 2.5 log, respectively, on the number of free 
S. epidermidis and S. aureus. 
Antimicrobial performance was also evaluated for a longer period of 
time, 10 days, to strengthen the application of these coatings in ortho-
pedics (Fig. 4C and D). Fig. 4C shows that both species adhered to 
control surfaces (SS and pDA), reaching similar values to the ones ach-
ieved after 24 h. Both one and two-step approaches completely pre-
vented the attachment of S. aureus during these 10 days of challenge. 
Regarding S. epidermidis, it was possible to observe some colonies 
adhered to the modified surfaces, after one-step approach. It should be 
stressed out, however, that more than 3 log reduction was still achieved. 
Surfaces further functionalized with PTX exhibited similar number of 
adhered cells of both species to the ones found on control surfaces (SS 
and pDA), an evidence that antimicrobial features provided by this 
approach were lost after being challenged for a longer period of time. 
Regarding the number of cells in the bulk phase (Fig. 4D), results 
showed that the presence of SS and pDA did not affect the growth of both 
species. Bacterial growth of both species was not compromised by the 
presence of surfaces further functionalized with PTX and no growth was 
observed when cells are near the surfaces modified with CHX, using both 
one and two-step approaches. 
3.4. Evaluation of resistance development by planktonic and adhered cells 
to CHX 
The ability of CHX to induce bacterial resistance was first determined 
when free in solution against planktonic cultures of S. epidermidis and 
S. aureus (Table 3). 
Results showed a 2-fold increase in MIC and MBC of both species, 
after 10 days of continuous exposure to a sub-inhibitory concentration of 
CHX, an evidence that planktonic cultures of S. epidermidis and S. aureus 
have become less susceptible to CHX. 
A similar assay was performed to evaluate the potential development 
of resistance towards immobilized CHX. For that, adhered cells, in 
Fig. 3. Surface characterization. Average roughness (A), contact angles (B) and 
CHX cumulative release (C) from SS surfaces before and after different pDA- 
based coating strategies for the immobilization of CHX/PTX. Significant dif-
ferences were found for (****) p < 0.0001, compared to SS and for (####) p <
0.0001 and (#) p < 0.05, compared to pDA. 
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contact with unmodified and modified SS surfaces for 10 days, were 
collected and used to determine the MIC and MBC of CHX. 
Results in Table 4 showed that cells recovered from modified sur-
faces displayed the same susceptibility patterns of cells in contact with 
control surfaces (SS and pDA), suggesting no development of resistance. 
When it comes to the 2step-CHX approach for both species and 1step- 
CHX for S. aureus, MIC and MCB could not be determined since no 
cells could be recovered from these surfaces (Fig. 4). 
3.5. Cytotoxicity of coatings 
To strengthen the applicability of the coating strategies as bio-
materials, their totoxicity on fibroblast cells was determined using the 
MTS assay (Fig. 5). 
Results showed that unmodified SS surfaces, before and after pDA 
coating, did not exhibit any cytotoxic effect, providing good conditions 
for fibroblasts growth. Further functionalization of surfaces with PTX or 
CHX using one-step approach did not compromise cells metabolic ac-
tivity, an evidence of no toxicity. The immobilization of CHX using the 
two-step approach, on the contrary, caused a reduction of cell viability 
superior to 30%. Therefore, it should be considered harmful and 
incompatible as biomaterial [32]. Cytotoxicity exhibited by this 
approach may be attributed to the higher release of CHX, since it has 
been previously shown that CHX toxicity towards mammalian cells was 
dose-dependent [43]. 
4. Discussion 
With the goal to fulfil the requirements of an anti-infective strategy 
for orthopedic implants, it was intended to design a coating strategy able 
to prevent bacterial attachment to the modified surfaces themselves, but 
also to the surrounding cells in the bulk phase. This should be accom-
plished with the combination of antimicrobial releasing and contact- 
killing features. CHX was chosen to impart surfaces with such antimi-
crobial features because of its antimicrobial mode of action. As a posi-
tively charged molecule, it has been postulated that CHX’s mode of 
action is mainly based on electrostatic interaction with bacterial mem-
branes with subsequent disruption of membrane’s structural stability 
[23]. Since CHX target is not intracellular, its immobilization should not 
compromise its antimicrobial action. Dopamine chemistry was used to 
tailor the immobilization of CHX and subsequent release from SS 
Fig. 4. Antimicrobial performance of SS surfaces before and after different pDA-based coating strategies for the immobilization of CHX/PTX against S. aureus and 
S. epidermidis for 24 h (A, B) and 10 days (C, D). The number of cells adhered to the surfaces (A, C) and in the bulk phase (B, D) was enumerated by CFU counting. 
Significant differences were found for (****) p < 0.0001, compared to cells adhered to SS or in the bulk phase in contact with SS. The dotted line on the graphs 
correspond to the detection limit of CFU counting (log 2 CFU mL− 1). 
Table 3 
Antimicrobial susceptibility of planktonic cultures of S. epidermidis and S. aureus 
towards CHX: MIC and MBC on day 0 and after 10 passages in a sub-inhibitory 
concentration of CHX. MIC and MBC are expressed in μg mL− 1.   
S. epidermidis S. aureus 
MIC MBC MIC MBC 
Day 0  0.4 0.4  0.4 0.8 
Day 10  0.8 0.4–0.8  0.8 0.8–1.6  
Table 4 
MIC and MBC of CHX against adhered S. epidermidis and S. aureus recovered from 
SS surfaces before and after different pDA-based coating strategies for the 
immobilization of CHX/PTX, after 10 days of exposure. MIC and MBC are 
expressed in μg mL− 1. ND denotes not determined.  
Surface S. epidermidis S. aureus 
MIC MBC MIC MBC 
SS 0.4 0.4 0.4 0.8 
pDA 0.4 0.4 0.4 0.8 
1step-CHX 0.4 0.4 ND ND 
2step-CHX ND ND ND ND 
PTX 0.4 0.4 0.4 0.8  
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surfaces, resulting in coating strategies with different surface properties, 
antimicrobial and biocompatible features. 
A previous work has highlighted the potential of the conventional 
two-step pDA-based approach for the immobilization of CHX on metallic 
surfaces, providing them with antimicrobial features and no cytotoxicity 
[37]. The present study demonstrated, however, that using smaller 
concentrations of both dopamine and CHX, an antimicrobial and 
releasing approach could still be generated. In terms of antimicrobial 
features, this strategy was able to eradicate both bacterial species in 
suspension, which suggests its ability to prevent bacterial contamination 
from the implant surface to the surrounding tissues, if applied in a 
clinical context [15]. Such powerful antimicrobial performance may be 
attributed to the higher amount of released CHX, based on the damage of 
the bacterial membrane of both S. aureus and S. epidermidis with sub-
sequent leakage of cytoplasmic content. However, this amount of CHX 
was also toxic to mammalian cells, a drawback often associated to 
antimicrobial releasing coating strategies [44]. The next step was, then, 
to modulate CHX release so that it retains its antimicrobial features 
without compromising the growth of mammalian cells, which was first 
performed by adding a layer of pDA to create an additional diffusion 
barrier [41]. 
A constriction associated to the two-step pDA-based immobilization 
strategy (involving the formation of a pDA layer before compound 
immobilization on top of this intermediate layer) is that the amount of 
the immobilized agent is limited to the amount of reactive quinone 
groups that can react, which, in turn, is limited to the surface area of the 
outer surface [40]. To overcome this limitation, a one-step procedure 
has been reported and it is characterized by dopamine self- 
polymerization in the presence of the compound. Such strategy results 
in the incorporation of active agents throughout the full thickness of the 
pDA layer rather than only at its outer surface [45]. CHX immobilization 
using this approach corroborated a previous work showing that this 
strategy results in a more homogeneous coating as compared to the 
conventional two-step approach [29]. In addition, improved surface 
features were obtained, namely the decrease on its roughness, a desired 
characteristic for further clinical application. In terms of antimicrobial 
performance, similar features were provided, as compared to the con-
ventional two-step approach, with the additional advantage of not 
compromising the growth of fibroblast cells. To strengthen the appli-
cability of this coating strategy on orthopedic devices, other line cells 
should be further tested, namely osteoblast-like cells. However, previous 
findings [46] demonstrating that SS functionalized with CHX was still 
able to induce the formation of apatite layer, and to support osteoblast 
cells attachment, differentiation and osteogenic maturation, are a good 
indication for the coating proposed in this study. 
Since it is well established that the first 6 h after implant surgery (the 
so-called “decisive period”) are critical to prevent infection and assure 
its long-term success, the coating strategies proposed in this study were 
tailored to release most of the CHX within the firs 6 h [47]. Furthermore, 
a rapid CHX initial release has previously proved to be effective in 
preventing S. aureus colonization of both the implants and surrounding 
tissue in a murine subcutaneous implant infection model [15]. Never-
theless, taking into account the long periods of time orthopedic devices 
are usually inserted in the human body, coating strategies designed for 
these devices should not quickly deplete the antimicrobial compound. 
For this reason, as well as to explain the observed antimicrobial per-
formance for up to 10 days, modified surfaces were immersed on PBS for 
24 h, under agitation. After this period, an antimicrobial and a leaching 
assay was then performed for both species and results confirmed that 
CHX was still immobilized after the first 24 h, as evidenced by the 
antimicrobial features (Fig. S5A) and presence of an inhibition zone 
(Fig. S5B). Inhibition zones were smaller than the ones found on Fig. S2, 
in which surfaces were not immersed on PBS. These outcomes reinforce 
that although most of CHX release has occurred in the first 3 h, which 
can be attributed to some physical adsorption, the continuous antimi-
crobial performance observed for a longer period of time may be 
attributed to a more stable CHX immobilization. We believe that a 
combined effect should take place: some bacterial killing was accom-
plished in the bulk phase by fast released CHX, impairing bacterial 
attachment to the surfaces, but also some killing by contact with CHX 
still immobilized should occur by electrostatic interaction. 
In this study, a contact-killing approach was used as a control of no 
CHX release. The absence of CHX release may be attributed to the 
presence of PEG in its composition, which enabled CHX immobilization 
on the surfaces [48]. The antimicrobial performance of this coating 
strategy observed after 24 h of bacterial challenge was lost when 
considering a longer period of time. Such results highlight the impor-
tance of achieving complete eradication of cells surrounding the sur-
faces, since the surviving cells will be able to proliferate and adhere to 
the implant surfaces. Moreover, after a contact of 24 h, a significant 
number of cells were still found attached to the modified surfaces which 
may be a sign of a problem often associated to contact-killing surfaces: 
the accumulation of dead bacteria on the surfaces [49]. So, even if the 
coating strategy is able to kill the first adherent cells, it may allow the 
attachment of other bacteria and its consequent proliferation, resulting 
in more bacterial accumulation on the surface, while simultaneously 
reducing the antimicrobial activity over time, which was observed in 
this study. 
Despite the CHX powerful antimicrobial features, its widespread use 
has led to some concerns regarding the emergence of bacterial resistance 
[50]. More recently, it has become the subject of great interest since it 
was reported that adaption in vitro of clinical isolates of Klebsiella 
Fig. 5. Viability of 3T3 fibroblast cells after indirect contact with SS surfaces before and after different pDA-based coating strategies for the immobilization of CHX/ 
PTX. The dotted line is the cells viability percentage (70%) used as higher limit for cell toxicity. Significant differences were found for (****) p < 0.0001, compared to 
viability cells after indirect contact with SS. 
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pneumoniae to CHX can result in stable resistance towards it, as well as 
cross-resistance towards the last line antibiotic colistin [51]. The 
Staphylococci strains used in this study also exhibited an in vitro adap-
tion to sub-inhibitory concentrations of CHX in solution, which 
strengthen these concerns. CHX immobilization can offer an advantage, 
as it has been showed that immobilized antimicrobial compounds show 
less propensity for developing bacterial resistance [52]. However, for 
antimicrobial releasing strategies, such as the ones presented in this 
study, a scenery in which the agent reaches sub-inhibitory concentra-
tions after its release can present a problem. In general, for both one-step 
and two-step pDA-based immobilization of CHX, a rapid initial release 
was obtained, being sufficient to effectively eradicate the cells sur-
rounding the surface and subsequently prevent their attachment. In such 
approaches, resistance development should not be an issue. For the 
strategies where adhered cells were found after 10 days of continuous 
challenge (PTX for both species and 1step-CHX for S. epidermidis), cells 
were recovered and their susceptibility to CHX was determined. Results 
showed that these cells exhibited a similar susceptibility pattern as the 
cells recovered from the control surfaces with no CHX (SS and pDA), 
thus suggesting no development of resistance in these conditions. These 
results corroborate the theory that compounds immobilization decreases 
their propensity to induce bacterial resistance [52,53]. It should also be 
mentioned that the probable very low amount of CHX still remaining on 
these surfaces can also contribute for this absence of resistance 
development. 
5. Conclusions 
In conclusion, dopamine chemistry was successfully applied to tailor 
the CHX immobilization and subsequent release from SS surfaces, 
resulting in coating strategies with different surface properties, antimi-
crobial and biocompatible features. Immobilization of CHX using a one- 
step pDA-based strategy proved to be the most promising approach to be 
further applied in the fight of infections associated to orthopedic im-
plants. This simpler approach provided the surfaces with the ability to 
prevent bacterial colonization of the surface, while eradicating bacteria 
surrounding the surface in suspension for 10 days long. The few bacteria 
that managed to adhere onto these surfaces did not show evidence of 
resistance towards CHX. Moreover, the released amount of CHX did not 
compromise the growth of mammalian cells. 
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